Invivyd

Invivyd

生物技术研究

Waltham,Massachusetts 11,711 位关注者

Devoted to delivering protection from serious viral infectious diseases.

关于我们

Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

网站
https://www.invivyd.com
所属行业
生物技术研究
规模
51-200 人
总部
Waltham,Massachusetts
类型
上市公司
创立
2020

地点

  • 主要

    1601 Trapelo Rd

    Suite 178

    US,Massachusetts,Waltham,02451

    获取路线

Invivyd员工

动态

相似主页

查看职位

融资